Construction of live vaccines using genetically engineered poxviruses: Biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D (eukaryotic expression vector/herpes simplex virus neutralization/herpes simplex virus protection/hepatitis B virus surface antigen antibodies)
Enzo Paoletti(New York State Department of Health), Dennis Panicali(Fox Chase Cancer Center), Susan Mercer(New York State Department of Health), Carol Samsonoff(New York State Department of Health), B R Lipinskas(New York State Department of Health)
Unknown
January 1, 2016
Cited by 0
Related Papers
Importance of the nef gene for maintenance of high virus loads and for development of AIDS
|Cell|1991|1.6k
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
|Journal of Clinical Oncology|2010|975
High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors
|Journal of Virology|1995|513
Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.
|Proceedings of the National Academy of Sciences|1982|503
Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
|The Journal of Immunology|2004|384